Rapamycin (Sirolimus 1mg.)

What is Rapamycin (Sirolimus 1mg.)?

Rapamycin (Sirolimus 1mg.) is a prescription medication classified as an mTOR inhibitor. Originally isolated from the bacterium Streptomyces hygroscopicus, it functions as a potent immunosuppressant. It is FDA-approved for use in organ transplant recipients to reduce the risk of rejection by modulating immune system activity. While primarily used in post-transplant care, ongoing research explores its potential in longevity, metabolic regulation, and certain rare diseases.

Key features

• Active Ingredient — Sirolimus 1mg per tablet.
• Pharmacological Class — mTOR inhibitor with immunosuppressive properties.
• Primary Use — Prevention of organ rejection in kidney transplant patients.
• Mechanism of Action — Inhibits the mTOR pathway, regulating cell growth and immune response.
• Prescription Required — Available only with authorized medical approval.
• Source — Derived from Streptomyces hygroscopicus fermentation.
• Brand Origin — Marketed by HealthyRXS for verified prescription fulfillment.

Who is Rapamycin (Sirolimus 1mg.) for?

This medication is intended for patients who have undergone organ transplantation, particularly kidney transplants, and require long-term immunosuppression. It may also be prescribed off-label in specific clinical contexts under physician supervision. Not suitable for general wellness or self-medication.

How does Rapamycin (Sirolimus 1mg.) compare?

Compared to standard immunosuppressants like cyclosporine or tacrolimus, Rapamycin offers a distinct mechanism by targeting the mTOR pathway rather than calcineurin, potentially reducing certain types of kidney toxicity. However, it may carry higher risks of metabolic side effects such as hyperlipidemia or impaired wound healing. It is not interchangeable with other immunosuppressants without medical oversight.